Abbott’s TactiCath Contact Force Ablation Catheter Receives FDA’s Approval for Atrial Fibrillation (AFib)

 Abbott’s TactiCath Contact Force Ablation Catheter Receives FDA’s Approval for Atrial Fibrillation (AFib)

Abbott’s TactiCath Contact Force Ablation Catheter Receives FDA’s Approval for Atrial Fibrillation (AFib)

Shots:

  • TactiCath is a sensor-enabled ergonomic designed catheter used for providing precise heart images while performing ablation procedures in real-time electrical activity
  • The approval leads to expansion of Abbott’s portfolio with EnSite Precision cardiac mapping system in combination with TactiCath allowing physicians to treat AFib
  • Abbott has three catheters with enabled sensors: Advisor HD Grid Mapping Catheter, FlexAbility Ablation Catheter including TactiCath which is being evaluated in 84 countries WW

Click here to read full press release/ article | Ref: Abbott | Image: Medical Product Sourcing

 

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post